Lupin gains 3% on tentative USFDA approval for contraceptive tablets

Nudovra is the generic versional Bayer HealthCare Pharmaceuticals Inc.'s Natazia tablets.

 Ripples Advisory


Share price of Lupin added 3 percent intraday Thursday as company received tentative USFDA approval for generic Nudovra tablets.

The company has received tentative approval for its Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest Tablets, 2 mg/2 mg and 2 mg/3 mg) tablets from the USFDA (United States Food and Drug Administration) to market a generic version of Bayer HealthCare Pharmaceuticals Inc.'s Natazia tablets.

Nudovra is the generic versional Bayer HealthCare Pharmaceuticals Inc.'s Natazia tablets. It is an estrogen/progestin combined oral contraceptive (COC), indicated for use by women to prevent pregnancy.

Nudovra had annual sales of approximately USD 31.4 million in the US.

At 09:38 hrs Lupin was quoting at Rs 911.95, up Rs 22.75, or 2.56 percent on the BSE.

Two days Free Trials and best services packages for dealing in Stock market click here to get >>Nifty Market Tips and Ripples Advisory One Missed call on @9644405056

No comments:

Post a Comment

Designed with by Way2themes | Distributed by Blogspot Themes